Effect van selegeline op mortaliteit bij de ziekte van Parkinson

David A M C van de Vijver; A. De Boer

Effect van selegeline op mortaliteit bij de ziekte van Parkinson

Translated title of the contribution: A controversial drug. Effect of selegiline on mortality in patients with Parkinson's disease

David A M C van de Vijver
, A. De Boer

Research output: Contribution to journal › Special issue › Professional

Translated title of the contribution	A controversial drug. Effect of selegiline on mortality in patients with Parkinson's disease
Original language	Dutch
Pages (from-to)	1602-1603
Number of pages	2
Journal	Pharmaceutisch Weekblad
Volume	134
Issue number	46
Publication status	Published - 19 Nov 1999

Keywords

levodopa
selegiline
drug safety
human
major clinical study
mortality
note
Parkinson disease
risk assessment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{3683ca56e23d49e186288aef0188d2bd,

title = "Effect van selegeline op mortaliteit bij de ziekte van Parkinson",

keywords = "levodopa, selegiline, drug safety, human, major clinical study, mortality, note, Parkinson disease, risk assessment",

author = "\{van de Vijver\}, \{David A M C\} and \{De Boer\}, A.",

year = "1999",

month = nov,

day = "19",

language = "Dutch",

volume = "134",

pages = "1602--1603",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "46",

}

TY - JOUR

T1 - Effect van selegeline op mortaliteit bij de ziekte van Parkinson

AU - van de Vijver, David A M C

AU - De Boer, A.

PY - 1999/11/19

Y1 - 1999/11/19

KW - levodopa

KW - selegiline

KW - drug safety

KW - human

KW - major clinical study

KW - mortality

KW - note

KW - Parkinson disease

KW - risk assessment

M3 - Special issue

SN - 0031-6911

VL - 134

SP - 1602

EP - 1603

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 46

ER -